PCM
ALAB icon

Prelude Capital Management’s Astera Labs ALAB Stock Holding History

Prelude Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Sell
885
-6,706
-88% -$1.78M 0.03% 593
2026
Q1 		$832K Buy
7,591
+6,264
+472% +$892K 0.06% 347
2025
Q4 		$221K Sell
1,327
-1,185
-47% -$198K 0.02% 998
2025
Q3 		$492K Sell
2,512
-7,303
-74% -$1.2M 0.04% 510
2025
Q2 		$887K Buy
9,815
+5,389
+122% +$426K 0.09% 289
2025
Q1 		$264K Buy
+4,426
New +$409K 0.02% 766

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Prelude Capital Management's ALAB Position: Q2 2026 in Review

Prelude Capital Management reduced its Astera Labs (ALAB) stake by 88% in Q2 2026, selling an estimated $1.78M and leaving 885 shares worth $427K. The position accounts for 0.03% of the portfolio, ranked #593.

Prelude Capital Management first reported a position in ALAB in Q1 2025 and has held it in 6 quarters since. The position peaked at $887K in Q2 2025. 991 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Prelude Capital Management held 885 shares of Astera Labs worth $427K as of Q2 2026.
  • Prelude Capital Management sold 6,706 Astera Labs shares in Q2 2026, an estimated $1.78M.
  • Astera Labs made up 0.03% of Prelude Capital Management's portfolio in Q2 2026, its #593 holding.
  • Prelude Capital Management first reported a position in Astera Labs in Q1 2025 and has held it in 6 quarters since.
  • Prelude Capital Management's Astera Labs position peaked at $887K in Q2 2025.
  • 991 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.